{"id":"W2600523014","doi":"10.3389/fonc.2017.00052","title":"Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine","year":2017,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Erlotinib; Nintedanib; Lung cancer; Context (archaeology); Oncology; Immunotherapy; Personalized medicine; Ramucirumab; Nivolumab; Angiogenesis; Internal medicine; Cancer; Chemotherapy; Overall survival; Bioinformatics; Lung; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004725998,0.0005261044,0.0007996994,0.001837472,0.000211745,0.0007075844,0.0005030742,0.0007406556,0.003376475],"category_scores_gemma":[0.0005713647,0.0001421186,0.0004523331,0.001548752,0.0003543551,0.001084843,0.0005643393,0.001673089,0.001371545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004997972,"about_ca_system_score_gemma":0.0009145095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006420424,"about_ca_topic_score_gemma":0.001500763,"domain_scores_codex":[0.9998624,0.00002573914,0.00002108843,0.00001877405,0.00005685753,0.0000150294],"domain_scores_gemma":[0.9997591,0.0001039272,0.0000367328,0.000007949536,0.00006910291,0.00002316378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005316704,0.00006160713,0.0001795114,0.01439999,0.000079978,0.0001763382,0.00005334216,0.0003176277,0.00159863,0.004092359,0.03204045,0.9469469],"study_design_scores_gemma":[0.00001372428,0.0000633781,0.0006864263,0.003012562,0.0000915648,0.001275979,0.00004476253,0.00008932879,0.0003724264,0.002058366,0.9922787,0.00001275997],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009876434,0.9986073,0.00009302673,0.000359968,0.0001946209,0.000002946172,0.00001096841,0.000005539599,0.000626892],"genre_scores_gemma":[0.0006629265,0.9983799,0.0001157401,0.0001897073,0.0002099966,0.000003135658,0.00001856129,0.00000103824,0.0004188989],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003376475,"threshold_uncertainty_score":0.01129544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03738282497124096,"score_gpt":0.4364721285986241,"score_spread":0.3990893036273831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}